All tools and calculators

Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Roche HoldingEli Lilly
Last price
€436.11$1,417.54
Currency
EUR
USD
€350B$1.3T
26.1846.01
€16.66$30.81
0.330.45
0$6.69
00.49%
Sector
HealthHealth
Employees
103,24950,000
Ticker
€ROP$LLY
Primary listing
XGATNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €ROP or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.
Sign up